Impact of implantable defibrillators and resynchronization therapy on outcome in patients with left ventricular dysfunction - A meta-analysis

Cardiology

Volumn 106, Issue 4, 2006, Pages 249-255

  Abdulla, Jawdat ^a,d   Haarbo, Jens ^a   Køber, Lars ^b   Torp Pedersen, Christian ^c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d NONE   (Denmark)

Author keywords

Biventricular pacing; Cardiac defibrillator; Cardiac resynchronization therapy; Exercise tolerance; Left ventricular dysfunction

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFIBRILLATOR; DISEASE CLASSIFICATION; EXERCISE TOLERANCE; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE SYSTOLIC DYSFUNCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 33751097281     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093234     Document Type: Article

References (34)

1. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, et al: Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-1581.
2. Shibata MC, Flather MD, Wang D: Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 2001;3:351-357.
3. Abdulla J, Pogue J, Abildstrøm SZ, Køber L, Christensen E, Pfeffer MA, Yusuf S, Torp-Pedersen C: Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction - a meta-analysis. Eur J Heart Fail 2006;8:90-96.
4. McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, et al: Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004;141:381-390.
5. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, et al: Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289:730-740.
6. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
7. Braun MU, Rauwolf T, Zerm T, Schulze M, Schnabel A, Strasser RH: Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones. Heart 2005;91:601-605.
8. Ermis C, Lurie KG, Zhu AX, Collins J, Vanheel L, Sakaguchi S, et al: Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2004;15:862-866.
9. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al: Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-2033.
10. Leclercq C CS, Lellouche D, Fossati F, Anselme F, Szekely L, et al: Upgrading from right-ventricular pacing to biventricular pacing in previously paced patients with advanced heart failure: a randomized controlled study. Eur Heart J 2003;24(suppl S):364.
11. Desai AS, Fang JC, Maisel WH, Baughman KL: Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 2004;292:2874-2879.
12. Cleland JG, Ghosh J, Freemantle N, Kaye GC, Nasir M, Clark AL, et al: Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 2004;6:501-508.
13. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS: Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004;44:2166-2172.
14. Lee DS, Green LD, Liu PP, Dorian P, Newman DM, Grant FC, et al: Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol 2003;41:1573-1582.
15. Ezekowitz JA, Armstrong PW, McAlister FA: Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 2003;138:445-452.
16. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
17. Garrigue S, Bordachar P, Reuter S, Jais P, Kobeissi A, Gaggini G, et al: Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study. Heart 2002;87:529-534.
18. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
19. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, et al: Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-1787.
20. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, et al: Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-1459.
21. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
22. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-2694.
23. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, et al: Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002;105:1453-1458.
24. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
25. Bigger JT Jr: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias aft er coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997;337:1569-1575.
26. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890.
27. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al: Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488.
28. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158.
29. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940.
30. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
31. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al: Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol 2003;41:1707-1712.
32. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1140.
33. Calvert M, Freemantle N, Cleland JG: Cardiac resynchronization therapy in heart failure. Ann Intern Med 2005;142:305-307; author reply 307-308.
34. Moss AJ, Vyas A, Greenberg H, Case RB, Zareba W, Hall WJ, et al: Temporal aspects of improved survival with the implanted defibrillator (MADIT-II). Am J Cardiol 2004;94:312-315.